The global microcrystalline cellulose market is growing steadily, valued at around US$ 1,556.9 million in 2025 and projected ...

AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quarter of 2026, reflecting strong launches in ...

Incyte (Nasdaq : INCY) a annoncé aujourd’hui les données finales à 24 semaines de l’essai de phase 3 TRuE-AD4 évaluant l’efficacité et l'innocuité de la crème Opzelura ® (ruxolitinib) chez les adultes ...

Supplementary protection certificates (SPCs) should not be granted for substances expressly designated as excipients within ...

The plant-based excipients market is poised for growth due to increasing demand for clean-label, natural, and allergen-free ...

Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...

Most prescriptions in the United States get filled at one of three large chain pharmacies. The system works for the majority of patients most of the time. The system also ...

In part 4 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, gives a preview of the ...

CPHI India and PMEC India will hold their pharmaceutical industry expos in two venues across Delhi-NCR this year, in an ...

InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for biologics manufacturing, announced its participation in the IPEC Excipient World Biologics Summit, which ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...